Engineers grow pancreatic “organoids” that mimic the real thing
Studying these organoids could help researchers develop and test new treatments for pancreatic cancer, one of the deadliest types of cancer.
Studying these organoids could help researchers develop and test new treatments for pancreatic cancer, one of the deadliest types of cancer.
Pioneering scientist isolated, characterized, and established the mechanisms of many environmental toxins relevant to public health.
Researchers find three immunotherapy drugs given together can eliminate pancreatic tumors in mice.
Diagnostic nanoparticles could be used to monitor tumor recurrence after treatment or to perform routine cancer screenings.
The Hansen Lab investigates how genetic elements, known as enhancers, control the expression of genes in cancer.
Implant surface topography can influence the development of scarring, inflammation, and other complications, researchers find.
Kytopen is speeding up both discovery and delivery of engineered cell therapies with its transformative Flowfect platforms.
Study suggests this process for eliminating unneeded cells may also protect against cancer.
Developing drugs that prevent this softening might impede tumors’ ability to spread.
Using deep convolutional neural networks, researchers devise a system that quickly analyzes wide-field images of patients’ skin in order to more efficiently detect cancer.
MIT biology professor and pioneering researcher of cancer cell metabolism will succeed longtime director Tyler Jacks.
MIT research combines machine learning with nanoparticle design for personalized drug delivery.
Delivering vaccines directly to the lungs can boost immune responses to respiratory infections or lung cancer, study finds.
Varying levels of a DNA repair enzyme can lead to very different outcomes after exposure to NDMA.
Tough as plastic wrap but elastic like a balloon, the lining could be a target for therapies to limit cancer cells from spreading.